January 2023

  • All
  • --
  • ---
  • -2022
  • 2022-2
  • 2022-2-2-2
  • 2022-deltia-tipoy
  • 2022-deltia-tipoy-2-2
  • 2022-deltia-tipoy-2-2-2-2
  • 2023-deltia-typou
  • 2023-deltia-typou-2-2
  • 2024
  • 257-2
  • 257-2-2-2
  • 266-2
  • Announcements
  • Consolidated Financial Results
  • deltia-tipoy
  • deltia-tipoy-2-2
  • deltia-tipoy-2-2-2-2
  • Distribution of Divident
  • Events
  • FAQ
  • General Meetings and Corporate Actions
  • Insiders Transactions Disclosures
  • Invitations
  • invitations-2
  • Presentations
  • Press Kits
  • Press Releases
  • Regulated Information
  • Results 2024
  • Share Capital Increase
  • Uncategorized

Peania, 27 January 2023 – Lavipharm received an award from the National and Kapodistrian University of Athens (NKUA) in recognition of its many years of activity in the research, development and production of pharmaceutical products and its longstanding collaboration with the Department of Pharmacy of...

A new page in its presence on the stock exchange Peania, 22 December 2022 – As of Friday, 23 December 2022, the shares of Lavipharm S.A. will be traded again on the Main Market of the Athens Stock Exchange. Following the completion of the share capital increase,...